Genscript - Model SARS-CoV-2 - Neutralizing Antibody Standard Antibodies
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 20SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease in 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells.
Formulation The SARS-CoV-2 Neutralizing Antibody Standard supplied in 0.2 μm filtered PBS, pH 7.4. The volume of this standard is 100 μL.
Properties
- Concentration 1,000,000 U/ml
- Unitage The unitage of this product has been defined as an arbitrary unit of 100,000 U.
- Stability The unopened product is stable up to the stated expiration date when stored at -20 °C. The opened product is stable for 1 month from the date of opening when stored at 2°C to 8°C.
- Storage This standard should be stored at -20 °C upon receipt until use. Avoid repeated freezing and thawing cycles.
- Note For Research Use Only. Not for Use in Diagnostic Procedures.
Working concentrations for specific applications should be determined by the researchers. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following is the recommended concentration range of starting point for this product.
- ELISA: 10 U/ml - 1000 U/ml
- Pseudovirus Neutralization Test (pVNT): 10 U/ml - 40,000 U/ml
- Plaque Reduction Neutralization Test (PRNT): 100 U/ml - 10,000 U/ml
- Other applications: user-optimized